![Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile](/docs/US/2023-11-07/US11807651B2/abs.jpg.600x600.jpg)
- Patent Title: Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
-
Application No.: US17401892Application Date: 2021-08-13
-
Publication No.: US11807651B2Publication Date: 2023-11-07
- Inventor: Charles Todd Eary , Stacey Spencer , Zack Crane , Katelyn Chando , Sylvie Asselin , Weidong Liu , Mike Welch , Adam Cook , Gabrielle R. Kolakowski , Andrew T. Metcalf , David A. Moreno , Tony P. Tang
- Applicant: Loxo Oncology, Inc. , Array BioPharma Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Loxo Oncology Inc.,Array BioPharma Inc.
- Current Assignee: Loxo Oncology Inc.,Array BioPharma Inc.
- Current Assignee Address: US IN Indianapolis; US CO Boulder
- Agent Bradley Wayne Crawford
- Main IPC: C07D519/00
- IPC: C07D519/00 ; C07D471/04
![Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile](/abs-image/US/2023/11/07/US11807651B2/abs.jpg.150x150.jpg)
Abstract:
In some embodiments, provided herein is a process for preparing a compound of Formula I
or a pharmaceutically acceptable salt thereof, as disclosed herein.
or a pharmaceutically acceptable salt thereof, as disclosed herein.
Public/Granted literature
Information query
